RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 41 filers reported holding RAIN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $777,916 | -28.4% | 902,664 | -0.3% | 0.00% | – |
| Q2 2023 | $1,086,205 | -85.9% | 905,171 | +2.7% | 0.00% | – |
| Q1 2023 | $7,700,727 | +112.5% | 881,090 | +94.5% | 0.00% | – |
| Q4 2022 | $3,624,208 | +69.6% | 453,026 | +3.5% | 0.00% | – |
| Q3 2022 | $2,137,000 | -12.2% | 437,746 | 0.0% | 0.00% | – |
| Q2 2022 | $2,434,000 | -7.8% | 437,746 | -16.0% | 0.00% | – |
| Q1 2022 | $2,641,000 | -59.6% | 521,033 | +2.7% | 0.00% | – |
| Q4 2021 | $6,534,000 | +11.8% | 507,275 | +29.9% | 0.00% | – |
| Q3 2021 | $5,843,000 | +3.2% | 390,544 | +7.2% | 0.00% | – |
| Q2 2021 | $5,661,000 | – | 364,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,571,379 | $7,967,000 | 2.01% |
| Cormorant Asset Management, LP | 2,326,660 | $11,796,000 | 0.91% |
| BVF INC/IL | 3,526,729 | $17,881,000 | 0.72% |
| Boxer Capital, LLC | 1,175,000 | $5,957,000 | 0.31% |
| Perceptive Advisors | 2,483,619 | $12,592,000 | 0.25% |
| Logos Global Management LP | 134,194 | $680,000 | 0.09% |
| Lumina Fund Management LLC | 6,000 | $30,000 | 0.01% |
| Woodline Partners LP | 119,700 | $607,000 | 0.01% |
| Trexquant Investment LP | 28,373 | $144,000 | 0.01% |
| Alyeska Investment Group, L.P. | 125,000 | $634,000 | 0.01% |